Delivery Order SPE2DR25D1053-SPE2DR26FT216
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,674.09 by the Defense Logistics Agency for the supply of Betaseron 0.3 mg kits, with a completion date of September 30, 2025. This firm fixed-price delivery order, awarded on September 29, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $11,859.47 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,155.37, is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, valued at $16,526.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Betaseron 0.3 mg kits, a specialty medication, with a completion date of December 22, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $30,974.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply Betaseron 0.3 mg kits. The delivery order was awarded on December 11, 2023 against an existing indefinite delivery contract held by Amerisourcebergen Drug Corp, with performance to be completed by December 12, 2023. The delivery location is Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical valued at $14,734.37. The contract is for the delivery of 0.3 mg BETASERON medication kits, which are specialty pharmaceutical products used to treat certain medical conditions. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,032.88 to Amerisourcebergen Drug Corporation for 4562055157 units of Betaseron 0.3 mg kits. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the multiple sclerosis drug to locations within Conshohocken, Pennsylvania under a one-day period of performance beginning September 5, 2023. The ordering agency, the Defense Logistics Agency, manages the Department of Defense's global logistics...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT216Delivery Order
The Defense Logistics Agency awarded a $35,801.16 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Betaseron is a disease-modifying therapy used to treat multiple sclerosis, consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceutical products delivered through its DLA contracts. The company's federal contract awards demonstrate consistent capability to fulfill medical supply requirements across multiple therapeutic domains, including neurological treatments, diabetes medications, and specialized medical commodities. This award reflects AmerisourceBergen's ongoing role as a primary vendor within the DLA's pharmaceutical supply chain, supporting Defense Health Agency procurement needs and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.8k | 10/22/25 |